This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

E2212

Eisai Co., Ltd.

Drug Names(s): E2212

Description: E2212 is a gamma secretase modulator. Gamma secretase is involved in the production of beta-amyloid, the major component of amyloid plaques seen in Alzheimer's disease. In preclinical studies, E2212 exhibited a more potent inhibition of the formation of amyloid beta (Aß42) by gamma secretase, apparently without impacting Notch-processing, a key process in normal cell differentiation that is also processed by gamma secretase.


E2212 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug